21 results
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis - Induction, Consolidation and Maintenance Therapy

Table 2. Antifungal Treatment Recommendations
for Cryptococcal ... Recommendations for Cryptococcal ... Recommendations for Cryptococcal ... #Treatment #management ... #meningitis #cryptococcus
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Inpatient Pnuemonia Management ... Algorithm - IDSA ... 2019 Guidelines ... #Algorithm #IDSA2019 ... #HAP #HCAP #Treatment
Inpatient Pnuemonia Management Algorithm - IDSA 2019 Guidelines

Carla Canepa MD https://www.instagram.com/_carlemd_/

#Pneumonia #Management #Algorithm #IDSA2019 #Guidelines #Inpatient
Inpatient Pnuemonia Management ... Algorithm - IDSA ... 2019 Guidelines ... #Algorithm #IDSA2019 ... #HAP #HCAP #Treatment
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... for Cryptococcal ... week) >1 year #Cryptococcal ... #Treatment #management ... #meningitis #cryptococcus
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Transplant Recipients
Induction therapy:
 • liposomal AmB (3–4 mg/kg per
IDSA Treatment Recommendations ... for Cryptococcal ... year B-III #Cryptococcal ... #Treatment #management ... #meningitis #cryptococcus
Clostridium Difficile Diagnosis and Management Algorithm

IDAGRAM based on most recent guidelines from @IDSAInfo.

 Infographic by IDagram
@ID_agram

#Clostridium
Diagnosis and Management ... Algorithm IDAGRAM ... on most recent guidelines ... Treatment #Diagnosis #Management ... #IDSA #CDiff
IDSA Risk Factors for Multidrug-Resistant Pathogens 

#Diagnosis #Management #InfectiousDiseases #MDRO #RiskFactors #HAP #VAP #HCAP #IDSA2016 #Guidelines
IDSA Risk Factors ... #Diagnosis #Management ... #RiskFactors #HAP ... #VAP #HCAP #IDSA2016 ... #Guidelines #Pneumonia
Microscopic Colitis - AGA Guideline Management ALgorithm

#Microscopic #Colitis #Management #Treatment #algorithm #gastroenterology
Microscopic Colitis ... - AGA Guideline ... Management ALgorithm ... #Microscopic # ... Colitis #Management
Spectrum of activity for systemic antifungal agents
Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
fluconazole; ISA ... Aspergillus fumigatus, Cryptococcus ... #antibiogram #management
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
Community-Acquired Pneumonia (CAP ... fluoroquinolone #IDSA ... #Outpatient #CAP ... Treatment #Regimen #Management ... #Guidelines #pharmacology